Nektar Announces Promising New and Corrected Rezpegaldesleukin Efficacy Data Which Were Previously Reported in 2022 and Incorrectly Calculated by Former Collaborator Eli Lilly & Company
finance.yahoo.com/news/...ed-rezpegaldesleukin-103000659.html
finance.yahoo.com/news/...ed-rezpegaldesleukin-103000659.html